Suchergebnisse - "Bettiol, Alessandra"

PubPharm (10)

1

Benralizumab for eosinophilic granulomatosis with polyangiitis : a retrospective, multicentre, cohort study

enthalten in: The Lancet. Rheumatology | 2023

von Bettiol, A. | Urban, M. | Padoan, R. | +48

2

Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA) : a European multicentre observational study

enthalten in: Annals of the rheumatic diseases | 2022

von Bettiol, A. | Urban, M. | Bello, F. | +39

3

Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus : post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou et al

enthalten in: Annals of the rheumatic diseases | 2022

von Bettiol, A. | Pregnolato, F. | Sciascia, S. | +3

CommentOn: Ann Rheum Dis. 2020 Feb;79(2):304-307. - PMID 31712248

4

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis : A European Multicenter Observational Study

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von Bettiol, A. | Urban, M. | Dagna, L. | +92

5

Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype : a multicentre study

enthalten in: Annals of the rheumatic diseases | 2020

von Fagni, F. | Bettiol, A. | Talarico, R. | +7

6

SARS-CoV-2 infection among patients with systemic autoimmune diseases

enthalten in: Autoimmunity reviews | 2020

von Emmi, G. | Bettiol, A. | Mattioli, I. | +5

CommentIn: Autoimmun Rev. 2020 Oct;19(10):102639. - PMID 32801048

7

The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome : a systematic review

enthalten in: Rheumatology international | 2019

von Bettiol, A. | Silvestri, E. | Di Scala, G. | +8

8

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases

enthalten in: International journal of molecular sciences | 2019

von Bettiol, A. | Lopalco, G. | Emmi, G. | +13

9

Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment

enthalten in: Autoimmunity reviews | 2019

von Emmi, G. | Bettiol, A. | Palterer, B. | +4

CommentOn: Ann Rheum Dis. 2018 Nov;77(11):1694-1695. - PMID 29776976

10

Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome : A preliminary study

enthalten in: Journal of autoimmunity | 2019

von Di Scala, G. | Bettiol, A. | Cojan, R. | +3

1
[1]